Anti-CD8 monoclonal antibody (CytoDyn)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-CD8 monoclonal antibody (CytoDyn)
Drug Alias NameCytolin
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionLeukocyte adhesion glycoprotein LFA-1 alpha modulatorsCluster of differentiation 8 inhibitors
TargetsLeukocyte adhesion glycoprotein LFA-1 alphaCluster of differentiation 8
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytodyn Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytodyn Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A